Professor Michael D Feher
Professor Michael D Feher is Consultant Physician in Diabetes and Clinical Pharmacology at the Chelsea & Westminster Hospital, London, and Visiting Professor within Clinical Informatics and Health Outcomes Research Group, Nuffield Department of Primary Care Health Sciences, University of Oxford.
He has had extensive clinical experience in diabetes, lipids and hypertension, combining clinical pharmacology, pharmaco-epidemiology and laboratory-based research with diabetes clinical care and teaching. Publications include eight books in diabetes and cardiovascular medicine.
He is an independent diabetes assessor to London Metropolitan/Home County Police. Committee membership of Heart UK, European Medicines Agency (EASD Diabetes representative and special advisory panel) and Secretary State for Transport Honorary Medical Advisory Panel (DVLA) panel for Driving and Diabetes. He is on the Editorial Board of the British J of Diabetes.
Dr. David Hopkins
Dr Hopkins is a Consultant Physician and Diabetologist. He is Clinical Director for King's diabetes service and Joint Clinical Academic Lead across King's Health Partners. Dr Hopkins leads one of the largest specialist diabetes teams in the UK. He conducts a wide range of specialist diabetes clinics including insulin pump management, diabetic nephropathy, autonomic neuropathy and gastrointestinal complications of diabetes. He qualified in medicine from Liverpool University and subsequently, trained in diabetes, endocrinology and internal medicine in Liverpool (1987-1995) and at King's (1995-1999) where he was a clinical academic group lead in 2014. Dr Hopkins was first appointed as a consultant at Central Middlesex Hospital in 1999 before returning to King's as a consultant in 2004. He became clinical director of the service in 2010 and clinical academic group lead in 2014. Dr Hopkins has broad research interests include management of hypoglycaemia, outcomes of structured patient education in type 1 diabetes and early detection of coronary artery disease in type 2 diabetes. He has national roles as a member of the Diabetes UK Council of Health Professionals and of the DAFNE executive. He acts as audit and quality assurance lead for the national DAFNE structured education programme.
Type 1 diabetes. Insulin pump treatment. Type 2 diabetes and complications
Diabetic kidney disease. Diabetic neuropathy. Gastrointestinal complications of diabetes. Diabetes management following bariatric surgery.
Professor David Russell-Jones
Prof. David Russell-Jones qualified from Guy’s and St Thomas Hospital medical school in 1985. He did his SHO training in the ‘golden circle’ of famous London postgraduate institutions, including the Hammersmith, Brompton, and Queens Square, before returning to St Thomas as registrar. He performed an MD under the direction of Professor Peter Sonksen.
He was appointed lecturer at Guy’s and St Thomas followed by Senior Lecturer and Consultant Physician in 1994. In 1998 he was appointed Professor of Diabetes and Endocrinology at the University of Surrey and Consultant Physician at the Royal Surrey County Hospital where he runs a full specialist diabetes and endocrine service for patients, including a large pituitary clinic. He is a full part of the general medical ‘take’ in addition to running specialist clinics and doing extensive research. He has recently been appointed by NHS England to be a member of the “Clinical Reference Group” for both specialist Endocrinology and specialist Diabetes. His department has attracted large research grants and was rated 5*A in the recent university research assessment exercise.
His research interests include the use of stable isotopes to understand peptide hormone physiology. He has published more than 100 peer reviewed papers on insulin, IGF-1, and growth hormone, he has also been asked to review for the world’s top Diabetes and Endocrine journals and wrote a lead article for the BMJ.
He is an invited speaker at prestigious diabetes and endocrine meetings all over the world and in the last few years has spoken at meetings in the USA, Canada, Finland, Belgium, Denmark, Sweden, Italy, France, Argentina, Ireland, Switzerland, China, India and Austria where he presented at the European Association for the Study of Diabetes (EASD) symposium on cancer and insulin which was attended by approximately 8000 delegates. He is also a past plenary speaker at the biannual meeting of the Growth Hormone Research Society and Principal Investigator of several multi-national clinical trials that have changed medical practice. In his spare time, he has an active interest in racing sailboats and has represented the UK in the past.
Professor Alice Cheng
Professor. Cheng is a member of the Division of Endocrinology and Metabolism at Trillium Health Partners in Mississauga and St. Michael's Hospital in Toronto and is an Associate Professor in the Department of Medicine at the University of Toronto. She completed medical school, internal medicine and Endocrinology training at the University of Toronto and has completed the Master Teacher Program offered through the Department of Medicine. She has served on the Expert Committee for the 2003 Diabetes Canada clinical practice guidelines, the Steering and Expert Committees for the 2008 revision and served as Chair of the 2013 Diabetes Canada clinical practice guidelines. She is currently the Chair of the Professional Section of Diabetes Canada and an Associate Editor for the Canadian Journal of Diabetes. She has received a Certificate of Recognition from the Ontario College of Family Physicians, the national Charles H. Best Award, and the Gerald S. Wong Service Award from Diabetes Canada in recognition of her contributions.
Professor Steve Bain
Professor Steve Bain is Assistant Medical Director for Research & Development for ABM University Health Board and Clinical Lead for the Diabetes Research Network, Wales.
After undergraduate training at St John's College, Cambridge, he was clinically trained at King's College Hospital, London. Qualifying in 1983, he held junior appointments in London, East Midlands, and West Midlands. His research centred on the genetics of type 1 diabetes, and he was granted a Medical Research Council Lectureship. In 1993, he became a Senior Lecturer/Honorary Consultant Physician at Birmingham Heartlands Hospital, with promotion to Reader in Diabetic Medicine in 1998. Professor Bain became a Fellow of the Royal College of Physicians, UK, in 1996 and was appointed to a newly created Chair in Medicine (Diabetes) at Swansea University in 2005. His clinical interests include the genetics of diabetic nephropathy, new therapies for diabetes and the provision of diabetes services within the community. He has been Principal Investigator for several multi-centre trials investigating novel therapies for diabetes.
As a result of his genetics background, Professor Bain became a member of the inaugural West Midlands Multicentre Research Ethics Committee (MREC) and joined the UK Human Genetics Commission. From 2003-2008 he was HGC’s nomination on the National DNA Database Strategy Board and led the HGC report on DNA testing in 2009. In 2007 he was invited to sit on the newly formed National DNA Database Ethics Group, established by the Secretary of State for the Home Department. Professor Bain is Diabetes Lead Clinician for ABM University Health Board, a member of the Wales Diabetes & Endocrine Society (WEDS) executive committee and chairs the Specialist Training Committee for Diabetes & Endocrinology for Wales. He is also on the Board which oversees the ILS Joint Clinical Research Facility, the premier clinical research institute in Wales and is Clinical Director of the Academic Health Science Collaboration for Wales.
Professor Richard M. Bergenstal
Richard M. Bergenstal, MD, is an endocrinologist and Executive Director of the International Diabetes Center at Park Nicollet. He is Clinical Professor in the Department of Medicine at the University of Minnesota and served as President, Science & Medicine of the American Diabetes Association in 2010. In 2007, Dr. Bergenstal was named the ADA’s Outstanding Physician Clinician of the Year and in 2010 he was awarded the Banting Medal for Service for outstanding leadership and service to the American Diabetes Association.Dr. Bergenstal received his MD and endocrine training from the University of Chicago where he was an Assistant Professor of Medicine before joining the International Diabetes Center in 1983.His clinical research has focused on glucose control and diabetes complications and he serves as a Principal Investigator of three NIH trials: the Diabetes Control and Complications Trial (DCCT) in type 1 diabetes and the Action to Control Cardiovascular Risks in Diabetes (ACCORD) study and the Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) study in type 2 diabetes.
Dr. Bergenstal’s clinical efforts have been directed toward improving systems of care for patients with diabetes by translating new research findings in to practice. He studies the effective utilization of insulin therapy and glucose monitoring (SMBG and CGM) to improve glucose control and clinical outcomes. He teaches nationally and internationally on the importance of patient-centered team care, has been listed in Best Doctors in America since it began in 1992, has published over 100 peer reviewed scientific articles in diabetes and has co-authored the best selling Betty Crocker Diabetes Cookbook.
Dr Ian Gray
Dr Gray has worked across a range of therapeutic areas and departments in different countries and at different levels of leadership at small/medium/arge pharmaceutical companies and academic organisations focusing on R&D, Manufacturing, Reg Affairs, PV, QA, Compliance, Medical Affairs and as a registered MHRA/HPRA Responsible Person in GDP and local Responsible Person for PV .
Professor Chantel Mathieu
Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology both on the basic and the clinical research side.Her work in animal models of type 1 diabetes has established 1,25-dihydroxyvitamin D3 as immune modulator and her demonstration of the potential of Lactococcus Lactis as carrier tool for peptides and proteins was the basis for a worldwide clinical trial in people with newly diagnosed type 1 diabetes. Her research group was amongst the first to demonstrate the relevance of post-translational modifications of beta-cell peptides and proteins in autoantigen generation in murine and human type 1 diabetes.
Her clinical work involving new products and treatment paradigms in diabetes, like new insulins, adjunct therapies in type 1 diabetes and diagnosis of gestational diabetes as well as her educational skills have made her a prominent speaker in international fora. Finally, her organizational skills were instrumental in shaping diabetes care in Belgium, promoting shared care, positioning of diabetes education and reimbursement of novel technologies. She is a co-author of several consensus papers, including the 2018-19 ADA/EASD Consensus on glucose lowering therapies in type 2 diabetes.
She leads presently the private-public partnership INNODIA sponsored through the EU’s Innovative Medicines Initiative INNODIA. This pan-European INNODIA project is a consortium of over 40 academic and industry partner institutions and 50 satellite clinical recruitment centers on biomarker discovery and interventions targeting prevention and arrest of type 1 diabetes. She has, from the beginning of the INNODIA project, put the people and families living with type 1 diabetes at the center of the work, through the establishment of the Patient Advisory Committee.
Since 2018, she is (senior) vice-president of EASD, chair of postgraduate education where she established an e-learning platform EASD LEARNING ORG and since 2020 she chairs the European Diabetes Forum EUDF.
Dr Peter Carey
Dr Peter Carey is a consultant in Diabetes and Endocrinology at South Tyneside and Sunderland and Regional Lipid Advisor to the AHSN-NENC.
He qualified from the University of Sheffield and trained initially in Liverpool before returning to the North East to undertake his MD in post prandial metabolism in type 2 diabetes and complete his specialty training.
His main clinical interests are Lipidology, Type 1 Diabetes and Thyroid disorders. He is actively involved in undergraduate teaching at the University of Sunderland Medical School. His work with the AHSN-NENC involves the implementation of the NHS England Cardiovascular Disease Prevention Programme through lipid optimisation, increased use of emerging therapies and identifying individuals with Familial Hypercholesterolaemia using primary care data searches.
Professor Pratik Choudhary
Prof. Pratik Choudhary is Professor of Diabetes at the University of Leicester, working with the dynamic team at the Leicester Diabetes Research Centre.
His clinical and academic interests are around type 1 diabetes and technology, with academic and clinical projects that integrate education, psychology and technology. He have a particular interest on helping embed new technology into clinical practice, to support health care providers as well as people living with diabetes.
Professor Choudhary also hold a position at King's College London, where he have on-going projects looking at central mechanisms of hypoglycaemia unawareness - using neuroimaging to work out why some people lose the ability trot recognise low glucose levels; as well as different strategies including education [ like DAFNE plus], psychology [ like our HARPdoc program.
He led a work-package focussed on continuous glucose monitoring within the EU-funded HYPORESOVLE consortium looking at different ways to reduce the impact of hypoglycaemia on people with diabetes. In addition to this Professor Choudhary is currently chair of the UK Diabetes Technology Network, member of the EASD postgraduate education committee , Associate Editor for Diabetic Medicine and member of the Secretary of State for Transport's Medical Advisory Panel for diabetes. He has worked with several academic and commercial partners on developing studies and products to help bring them to market.
Professor Melanie Davies
Melanie Davies is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust, Leicester, UK. She is based in the Diabetes Research Centre which is affiliated with the Department of Health Sciences at the University of Leicester. She is also the Co-Director of the Leicester Diabetes Centre, which has over 140 research staff, at the University Hospitals of Leicester NHS Trust. She trained at Sheffield and then completed her training at Cambridge, Ipswich, and Leicester.
Professor Davies’ research interests include the causes, screening, prevention, self-management, and treatment of type 2 diabetes mellitus. She is a National Institute for Health Research Senior Investigator and Director of the NIHR Lifestyle and Physical Activity BRU. Professor Davies is the Principal Investigator on a number of large global studies in the field of diabetes, obesity, physical activity, sedentary behaviour and cardiovascular disease and has served as an expert for the National Institute for Health and Care Excellence (NICE) on a number of guideline groups.
Professor Davies has published over 405 original articles in national and international peer-reviewed journals, such as the Lancet, NEJM and the BMJ and has over £60M of peer review grant funding. She has over 490 published abstracts and 10 book chapters and is Co-editor of the diabetes section in the 2011 Oxford Textbook of Endocrinology and Diabetes. She was awarded the CBE in the 2016 New Year’s Honour’s List for services to diabetes research.
Professor Anne Dornhorst
Professor Anne Dornhorst is a Consultant Physician and Professor of Practice at Imperial College London. Anne qualified in medicine from Oxford University and completed her postgraduate training in diabetes and endocrinology at the Johns Hopkins Hospital in Baltimore, USA, and St Mary’s Hospital London. After her return to the UK she has built up an international reputation in the field of diabetes. Her current position is based at the Hammersmith Hospital in London, where her main clinical interest and expertise are in the field of diabetes in pregnancy, nutrition, and diabetic kidney disease. Anne has contributed to the national diabetes guidelines in England. Anne has an interest in diabetes healthcare delivery and is a member of the London Diabetes Clinical Network and actively involved in her local STP diabetes transformation in NW London as well as being the Secondary Care Consultant for the Richmond CCG.